bpc-157 upregulates growth hormone receptor vs. TB-500, CJC-1295, and More: Comparative Insights in Peptide Research Peptide Therapy for Inflammation: A

The mechanism targets tissue repair rather than acid suppression, so it addresses a different part of the healing pathway

Dosing depends entirely on the form: the DAC version is dosed roughly once or twice weekly because of its extended half-life, while the non-DAC version (Mod GRF 1-29) is dosed more frequently, often before bed or post-workout, to align with natural GH pulses

this protocol is educational only BPC-157 is a synthetic peptide modeled after a sequence found in gastric proteins and has been explored in preclinical research for its potential influence on nitric oxide signaling, angiogenesis, and collagen-related repair pathways

wound healing

It doesn't significantly increase cortisol or prolactin, hormones that often rise with other secretagogues